KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Operating Expenses: 2009-2024

Historic Operating Expenses for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $751.0 million.

  • Charles River Laboratories International's Operating Expenses fell 10.85% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year decrease of 1.30%. This contributed to the annual value of $751.0 million for FY2024, which is 0.42% up from last year.
  • Per Charles River Laboratories International's latest filing, its Operating Expenses stood at $751.0 million for FY2024, which was up 0.42% from $747.9 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Operating Expenses ranged from a high of $751.0 million in FY2024 and a low of $528.9 million during FY2020.
  • Its 3-year average for Operating Expenses is $721.3 million, with a median of $747.9 million in 2023.
  • Data for Charles River Laboratories International's Operating Expenses shows a peak YoY grew of 17.20% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Operating Expenses stood at $528.9 million in 2020, then increased by 17.20% to $619.9 million in 2021, then increased by 7.29% to $665.1 million in 2022, then rose by 12.44% to $747.9 million in 2023, then rose by 0.42% to $751.0 million in 2024.